SCIENION announces expansion in the UK with the opening of new R&D and manufacturing facilities
SCIENION’s UK operations to become global hub for contract manufacturing services
SCIENION’s UK operations to become global hub for contract manufacturing services
Armin Rehm and Uta Höpken want to improve our immune defenses against cancer. They have recently shown in human cells what was previously only possible in mouse models. Their findings, published in "Molecular Therapy", have raised the chances of a…
An MDC research team led by Jan Philipp Junker and Daniela Panáková has found that zebrafish can regenerate heart tissue after injury. Connective tissue cells play an important role in the process by temporarily entering an activated state, as the…
Berlin, 20 July 2022. Eckert & Ziegler (ISIN DE0005659700, SDAX) and the Belgian biotech company PRECIRIX NV (PRECIRIX) have signed an agreement for the supply of Actinium-225. This gives PRECIRIX priority access to Eckert & Ziegler's high-purity,…
The way the genome is folded regulates gene activation, so it can’t be left to chance. Molecular boundaries across the genome keep things in order. A team led by MDC researcher Darío Lupiáñez has discovered how these boundaries work. Their findings,…
CDL-Berlin is located in Germany’s most vibrant startup ecosystem and hosted by ESMT Berlin, Germany’s #1 business school. By being deeply embedded in Germany’s deep tech economy, ESMT holds close ties with top-tier research institutions,…
Seoul, South Korea, and Berlin, Germany – (July 12, 2022) – LegoChem Biosciences Inc. (LCB) and Glycotope GmbH (Glycotope) have signed a Research Collaboration and License Agreement to develop an antibody drug conjugate (ADC) by combining LCB’s…
Two presentations at LINC 2022 focus on the performance of BIOTRONIK’s drug-coated balloon as a standalone therapy or combined with selective stenting following suboptimal angioplasty in challenging femoropopliteal lesions
Berlin, 6 July 2022. Eckert & Ziegler (ISIN DE0005659700, SDAX) has signed an agreement with the U.S. pharmaceutical company Ratio Therapeutics Inc. for the joint development and manufacture of innovative radiopharmaceutical products based on Lu-177…
Medical students: Charité most popular as an employer